Herbal treatment for pneumoconiosis
Part of Lungs & breathing clinical trials.
This study tests a modified traditional Chinese herbal formula (Qing-Zao-Jiu-Fei Decoction) to see if it helps people with pneumoconiosis (a chronic lung disease caused by dust exposure). The treatment aims to reduce symptoms and improve lung health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 85 years old.
- You need a confirmed diagnosis of pneumoconiosis (a lung disease caused by inhaling dust).
- You must be willing to have blood tests, fill out questionnaires, and take the study medication as scheduled.
- You cannot be taking other Chinese medicine regularly in the past 2 weeks.
- You cannot have certain other serious health conditions like other lung fibrosis, heart disease, cancer (within 5 years), or severe kidney/liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a long-term group of people with pneumoconiosis to better understand the disease and how dust exposure affects health. It does not involve any new treatments or medicines.
This Phase 3 trial tests whether pirfenidone slows or improves lung damage in people with silicosis or coal worker’s pneumoconiosis. It looks at both effectiveness and side effects, and uses lung function tests and lung scans to track changes over time.
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
This trial tests a traditional Chinese herbal formula, modified Ma Xing Shi Gan decoction, as an add-on treatment for people hospitalized with a sudden worsening (acute exacerbation) of chronic obstructive pulmonary disease (COPD), specifically when symptoms suggest a pattern called phlegm-heat. The goal is to see if this herbal treatment helps ease symptoms and improve recovery.
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
This study tests a traditional Chinese herbal recipe (Bufei) to see if it can reduce the number of people who develop chronic obstructive pulmonary disease (COPD). It is for people who have a history of chronic cough, phlegm, or shortness of breath and certain risk factors like smoking.
Hear when a new Pneumoconiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.